A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
Trial details
- Registry ID
- NCT05519839
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination VaccineNCT05519839 | Novavax | Phase 2 | Completed | 2023-07-25Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |